Advertisement
Screener

CAPRICOR THERAPEUTICS, INC. (CAPR) Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

CAPRICOR THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

CAPRICOR THERAPEUTICS, INC. (CAPR) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $399.69 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-03-17

  • CAPRICOR THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2025 was $399.69K, a 0.00% change from fiscal 2024.
  • CAPRICOR THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2024 was $399.69K.
  • CAPRICOR THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2012 was $2.12K, a 85.59% decline from fiscal 2011.
  • CAPRICOR THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2011 was $14.70K.
Period endEffective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month
2025-12-31$399.69K
10-K · filed 2026-03-17
2024-12-31$399.69K
10-K · filed 2026-03-17
2012-12-31$2.12K
10-K · filed 2013-06-21
2011-12-31$14.70K
10-K · filed 2013-06-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Evolus, Inc. (EOLS)United States$0.519B-13.32
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63